Progession of AML treatment over the past decades
Trial results and drug combinations for bortezomib in multiple myeloma
Can ibrutinib be used as a first-line treatment in CLL?
How to manage relapsed/refractory MCL - new agents and unmet needs
'Chemo-free' in follicular lymphoma